Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Csernok

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Scandinavian Journal of Gastroenterology|September 1, 1996
Target antigen for anti-neutrophil cytoplasmic antibodies in inflammatory bowel diseaseM P Stoffel, E Csernok, W L Gross
Clinical and Experimental Rheumatology|October 24, 2008
Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosisE Csernok, J U Holle, W L Gross
Lancet (London, England)|June 8, 1991
ANCA and infectionW H Schmitt, E Csernok, W L Gross
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1991
Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspectiveW L Gross, W H Schmitt, E Csernok
American Journal of Respiratory and Critical Care Medicine|February 15, 2000
Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener's granulomatosisA Schnabel, E Csernok, J Braun, et al.
Thorax|August 24, 1999
Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndromeA Schnabel, E Csernok, J Braun, et al.
Rheumatology (Oxford, England)|November 8, 2002
A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitisE Csernok, D Ahlquist, S Ullrich, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Update on the pathogenesis of Churg-Strauss syndromeB Hellmich, S Ehlers, E Csernok, et al.
Clinical and Experimental Rheumatology|August 26, 1998
ANCA, anti-alpha-enolase antibodies and cryoglobulinemic vasculitis: pathogenetic implicationsP Lamprecht, A Schnabel, E Csernok, et al.
Rheumatology (Oxford, England)|March 21, 2001
Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCAU Schönermarck, P Lamprecht, E Csernok, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Gastroenterology|September 1, 1996
Target antigen for anti-neutrophil cytoplasmic antibodies in inflammatory bowel diseaseM P Stoffel, E Csernok, W L Gross
Clinical and Experimental Rheumatology|October 24, 2008
Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosisE Csernok, J U Holle, W L Gross
Lancet (London, England)|June 8, 1991
ANCA and infectionW H Schmitt, E Csernok, W L Gross
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1991
Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspectiveW L Gross, W H Schmitt, E Csernok
American Journal of Respiratory and Critical Care Medicine|February 15, 2000
Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener's granulomatosisA Schnabel, E Csernok, J Braun, et al.
Thorax|August 24, 1999
Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndromeA Schnabel, E Csernok, J Braun, et al.
Rheumatology (Oxford, England)|November 8, 2002
A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitisE Csernok, D Ahlquist, S Ullrich, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Update on the pathogenesis of Churg-Strauss syndromeB Hellmich, S Ehlers, E Csernok, et al.
Clinical and Experimental Rheumatology|August 26, 1998
ANCA, anti-alpha-enolase antibodies and cryoglobulinemic vasculitis: pathogenetic implicationsP Lamprecht, A Schnabel, E Csernok, et al.
Rheumatology (Oxford, England)|March 21, 2001
Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCAU Schönermarck, P Lamprecht, E Csernok, et al.
Pageof 11